A deep learning model using echocardiography accurately detects cardiac amyloidosis, outperforming traditional methods.
Key Details
- 1AI model trained on echocardiography video clips from 2,612 patients across multiple sites and ethnic groups.
- 2External validation performed on 18 global sites; included 597 amyloidosis cases and 2,122 controls.
- 3Achieved AUROC of 0.93 (after excluding 13% uncertain predictions), sensitivity of 85%, specificity of 93%.
- 4Performance was consistent across amyloidosis subtypes and various subgroups.
- 5The AI model outperformed transthyretin cardiac amyloidosis (TTR-CA) score (AUROC = 0.73) and wall thickness scoring (AUROC = 0.8).
- 6Ultromics employees contributed and funded the study.
Why It Matters
This work demonstrates the robust, generalizable performance of AI to enhance echocardiographic detection of cardiac amyloidosis, surpassing current clinical scoring tools and suggesting real-world impact for earlier and more accurate diagnosis in routine practice.
Source
AuntMinnie
Related News
•Radiology Business
CARPL.ai Raises $10M to Expand Radiology AI Marketplace
CARPL.ai secured $10M in Series A funding to expand its global radiology AI marketplace.
•Radiology Business
AI-Powered Tool Streamlines CT Scan Prioritization in Emergency Departments
An AI-based CT queue system significantly reduces wait times for ED patients by prioritizing scans likely to reveal critical findings.
•Radiology Business
AI Workflow Enables General Radiologists to Match Breast Specialists in Screening
AI-powered workflow helps generalist radiologists detect breast cancer at rates comparable to specialists.